Clinical Study

Lifestyle Intervention Improves Heart Rate Recovery from Exercise in Adults with Type 2 Diabetes: Results from the Look AHEAD Study

Table 1

Heart rate variables at baseline (a) and Year 1 (b) for participants with and without β-blocker use. Values are mean (SD).

No -blocker use -blocker use
Variable
ILI ( baseline, 1743 Y1)DSE ( baseline, 1712 Y1) value (DSE versus ILI)ILI ( baseline, 562 Y1)DSE ( baseline, 485 Y1) value (DSE versus ILI)

(a) Baseline*Resting heart rate (b/min)79.35 (11.85)79.42 (11.75)0.868370.12 (10.96)69.66 (11.18)0.5228
Peak heart rate (b/min)154.2 (12.78)154.2 (13.13)0.8702130.8 (18.73)130.8 (19.40)0.9557
Heart rate range (b/min)74.93 (14.90)74.67 (15.20)0.612560.73 (15.70)61.01 (16.54)0.7895
Heart rate at 2 minutes recovery (b/min)112.1 (14.59)112.5 (20.40)0.553995.72 (16.16)94.80 (16.40)0.3832
Heart rate recovery (b/min)42.16 (12.67)41.62 (19.15)0.330035.15 (11.95)35.62 (12.22)0.5449

(b) Year 1*Resting heart rate (b/min)72.77 (11.35)77.68 (11.73)<.000165.89 (11.59)68.80 (11.12)<.0001
Peak heart rate (b/min)130.5 (6.24)130.8 (6.60)0.1355117.7 (17.87)118.7 (17.99)0.3539
Heart rate range (b/min)57.69 (12.06)53.11 (12.35)<.000151.80 (15.34)49.83 (15.34)0.0396
Heart rate at 2 minutes Recovery (b/min)89.30 (21.75)92.96 (12.14)<.000182.97 (15.43)85.89 (15.15)0.0021
Heart Rate Recovery (b/min)41.17 (22.02)37.84 (12.47)<.000134.71 (12.16)32.82 (11.54)0.0105

*Note that the baseline (a) was a maximal test while the Year 1 (b) test was submaximal.